CDK2 specific degraders (NiKang Therapeutics)

N/A

Report date: 2025/06/11 11:24:32
NME

Base Information

Drug NameCDK2 specific degraders (NiKang Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionCyclin-dependent kinase 2 inhibitorsAnticancer protein kinase inhibitors
TargetsCyclin-dependent kinase 2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNiKang Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNiKang Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A